It is known that the CV protection effect of GLP-1RAs have been proven through eight large-scale clinical studies, including Evaluation of LIXisenatide in Acute coronary syndrome (ELIXA) [66], LEADER [44], Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN)-6 [67], Exenatide Study of Cardiovascular Event Lowering (EXSCEL) [68], Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes) [69], Researching Cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) [70], Peptide Innovation for Early Diabetes Treatment (PIONEER) 6 [67,71], and AMPLITUDE-O [51]
A few interventions have real evidence
Expert Insight: "The Science Behind Skin Health" The skin contains approximately 15% of the body's total glutathione stores
published findings are primarily pre-clinical and exploratory
The fix is simple but often forgotten: recalculate using the actual water volume you added
This condition can be treated by a radiologist who re-expands the shunt with a balloon or repeats the procedure to place a new stent
